Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 4 Interventional

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

ClinicalTrials.gov ID: NCT05322070

Public ClinicalTrials.gov record NCT05322070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 4 Study of YUTIQ® (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uveitis (intraocular inflammation) that has responded to previous steroid therapy.

Study identification

NCT ID
NCT05322070
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Alimera Sciences
Industry
Enrollment
125 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2022 (Actual)
Primary completion
Nov 2025 (Estimated)
Completion
Nov 2025 (Estimated)
Last update posted
Aug 6, 2024

2022 – 2025

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Retina Consultants of Orange County Fullerton California 92835 —
Macula and Retina Institute Glendale California 91203 —
California Eye Specialists Medical Group Pasadena California 91107 —
Retinal Consultants Medical Group Sacramento California 95825 —
Retina Associates of Colorado Lakewood Colorado 80228 —
Advanced Research Coral Springs Florida 33067 —
Retina Specialists of Tampa Wesley Chapel Florida 33544 —
Marietta Eye Clinic Marietta Georgia 30060 —
Retinal Vitreal Consultants Ltd. Chicago Illinois 60616 —
Illinois Retina Associates, S.C. Oak Park Illinois 60304 —
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 —
Opthalmic Consultants of Boston Boston Massachusetts 02114 —
Massachusets Eye Research and Surgery Institution Waltham Massachusetts 02451 —
Foundation for Vision Research Grand Rapids Michigan 49546 —
Midwest Vision Research Foundation at Pepose Vision Institute Chesterfield Missouri 63017 —
Retina Consultants Fargo North Dakota 58104 —
Retina Vitreous Associates Toledo Ohio 43623 —
Erie Retina Research, LLC Erie Pennsylvania 16507 —
Tennessee Retina Nashville Tennessee 37203 —
Retina Consultants of Texas Bellaire Texas 77401 —
Retina Consultants of Texas Katy Texas 77494 —
Valley Retina Institute, PA McAllen Texas 78503 —
Medical Center Opthalmology Associates San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05322070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05322070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →